Cargando…

Production of mesenchymal stromal/stem cells according to good manufacturing practices: a review

Because of their multi/pluripotency and immunosuppressive properties, mesenchymal stem/stromal cells (MSCs) are important tools for treating immune disorders and for tissue repair. The increasing use of MSCs, their definition as advanced-therapy medicinal products in European regulations, and the US...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sensebé, Luc, Gadelorge, Mélanie, Fleury-Cappellesso, Sandrine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3707032/ https://www.ncbi.nlm.nih.gov/pubmed/23751270 http://dx.doi.org/10.1186/scrt217

Ejemplares similares

Biodistribution of Mesenchymal Stem/Stromal Cells in a Preclinical Setting
por: Sensebé, Luc, et al.
Publicado: (2013)

Platelet lysate from whole blood-derived pooled platelet concentrates and apheresis-derived platelet concentrates for the isolation and expansion of human bone marrow mesenchymal stromal cells: production process, content and identification of active components
por: Fekete, Natalie, et al.
Publicado: (2012)

CD146 expression on mesenchymal stem cells is associated with their vascular smooth muscle commitment
por: Espagnolle, Nicolas, et al.
Publicado: (2014)

Safety Profile of Good Manufacturing Practice Manufactured Interferon γ‐Primed Mesenchymal Stem/Stromal Cells for Clinical Trials
por: Guess, Adam J., et al.
Publicado: (2017)

Current good manufacturing practice considerations for mesenchymal stromal cells as therapeutic agents
por: Sanz-Nogués, Clara, et al.
Publicado: (2021)

Tips and Tricks for Validation of Quality Control Analytical Methods in Good Manufacturing Practice Mesenchymal Stromal Cell Production
por: Viganò, Mariele, et al.
Publicado: (2018)

Mesenchymal Stem/Stromal Cell Production Compliant with Good Manufacturing Practice: Comparison between Bone Marrow, the Gold Standard Adult Source, and Wharton’s Jelly, an Extraembryonic Source
por: Laroye, Caroline, et al.
Publicado: (2019)

Inactivated human platelet lysate with psoralen: a new perspective for mesenchymal stromal cell production in Good Manufacturing Practice conditions
por: Castiglia, Sara, et al.
Publicado: (2014)

A New Human Platelet Lysate for Mesenchymal Stem Cell Production Compliant with Good Manufacturing Practice Conditions
por: Mareschi, Katia, et al.
Publicado: (2022)

Human Synovial Mesenchymal Stem Cells Good Manufacturing Practices for Articular Cartilage Regeneration
por: Fernandes, Tiago Lazzaretti, et al.
Publicado: (2018)

Functional Comparison between Healthy and Multiple Myeloma Adipose Stromal Cells
por: Espagnolle, Nicolas, et al.
Publicado: (2020)

Good manufacturing practices for medicinal products for human use
por: Gouveia, Bruno G., et al.
Publicado: (2015)

Culture and Use of Mesenchymal Stromal Cells in Phase I and II Clinical Trials
por: Philippe, Bourin, et al.
Publicado: (2010)

CD54-Mediated Interaction with Pro-inflammatory Macrophages Increases the Immunosuppressive Function of Human Mesenchymal Stromal Cells
por: Espagnolle, Nicolas, et al.
Publicado: (2017)

Inter-center comparison of good manufacturing practices-compliant stromal vascular fraction and proposal for release acceptance criteria: a review of 364 productions
por: François, Pauline, et al.
Publicado: (2021)

Compliance with Good Manufacturing Practice in the Assessment of Immunomodulation Potential of Clinical Grade Multipotent Mesenchymal Stromal Cells Derived from Wharton’s Jelly
por: Grau-Vorster, Marta, et al.
Publicado: (2019)

Good manufacturing practice-compliant isolation and culture of human umbilical cord blood-derived mesenchymal stem cells
por: Pham, Phuc Van, et al.
Publicado: (2014)

Considering Cell Therapy Product “Good Manufacturing Practice” Status
por: Bedford, Patrick, et al.
Publicado: (2018)

Exosomes in clinical trial and their production in compliance with good manufacturing practice
por: Chen, Yu-Shuan, et al.
Publicado: (2019)

Identification and validation of multiple cell surface markers of clinical-grade adipose-derived mesenchymal stromal cells as novel release criteria for good manufacturing practice-compliant production
por: Camilleri, Emily T., et al.
Publicado: (2016)

Physiologic isolation and expansion of human mesenchymal stem/stromal cells for manufacturing of cell‐based therapy products
por: Egger, Dominik, et al.
Publicado: (2021)

A Novel Xeno-Free Method to Isolate Human Endometrial Mesenchymal Stromal Cells (E-MSCs) in Good Manufacturing Practice (GMP) Conditions
por: Canosa, Stefano, et al.
Publicado: (2022)

Food and Drink - Good Manufacturing Practice
por: Manning, Louise
Publicado: (2018)

Urokinase-type plasminogen activator receptor interaction with β1 integrin is required for platelet-derived growth factor-AB-induced human mesenchymal stem/stromal cell migration
por: Chabot, Valérie, et al.
Publicado: (2015)

Good Manufacturing Practice (GMP) Compliance for Phage Therapy Medicinal Products
por: Bretaudeau, Laurent, et al.
Publicado: (2020)

Human Platelet Lysate for Good Manufacturing Practice-Compliant Cell Production
por: Oeller, Michaela, et al.
Publicado: (2021)

Good manufacturing practices for pharmaceuticals : a plan for total quality control
por: Willig, Sidney H., 1919-
Publicado: (1997)

Mesenchymal Stromal Cells: From Discovery to Manufacturing and Commercialization
por: Mizukami, Amanda, et al.
Publicado: (2018)

CD200R/CD200 Inhibits Osteoclastogenesis: New Mechanism of Osteoclast Control by Mesenchymal Stem Cells in Human
por: Varin, Audrey, et al.
Publicado: (2013)

The requirements for manufacturing highly active or sensitising drugs comparing Good Manufacturing Practices
por: Fabio, Petrelli, et al.
Publicado: (2019)

A Simple Kit for the Good-Manufacturing-Practice Production of [(68)Ga]Ga-EDTA
por: Skulska, Monika, et al.
Publicado: (2023)

Ex vivo-expanded highly pure ABCB5(+) mesenchymal stromal cells as Good Manufacturing Practice-compliant autologous advanced therapy medicinal product for clinical use: process validation and first in-human data
por: Kerstan, Andreas, et al.
Publicado: (2020)

Translating Research into Clinical Scale Manufacturing of Mesenchymal Stromal Cells
por: Bieback, Karen, et al.
Publicado: (2011)

A New Human Platelet Lysate for Mesenchymal Stem Cell Production Compliant with Good Manufacturing Practice Conditions Preserves the Chemical Characteristics and Biological Activity of Lyo-Secretome Isolated by Ultrafiltration
por: Mareschi, Katia, et al.
Publicado: (2022)

Mass Spectrometry-based Absolute Quantification of 20S Proteasome Status for Controlled Ex-vivo Expansion of Human Adipose-derived Mesenchymal Stromal/Stem Cells
por: Menneteau, Thomas, et al.
Publicado: (2019)

Rationale for Determining the Functional Potency of Mesenchymal Stem Cells in Preventing Regulated Cell Death for Therapeutic Use
por: Naji, Abderrahim, et al.
Publicado: (2016)

Bone regeneration: the stem/progenitor cells point of view
por: Deschaseaux, Frédéric, et al.
Publicado: (2010)

Generation of Transplantable Retinal Photoreceptors from a Current Good Manufacturing Practice‐Manufactured Human Induced Pluripotent Stem Cell Line
por: Zhu, Jie, et al.
Publicado: (2017)

Production and validation of a good manufacturing practice grade human fibroblast line for supporting human embryonic stem cell derivation and culture
por: Prathalingam, Nilendran, et al.
Publicado: (2012)

Development of genetic quality tests for good manufacturing practice-compliant induced pluripotent stem cells and their derivatives
por: Jo, Hye-Yeong, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_upecrghnh5f1ctd2d6bqtk1l8u